Collegium Pharmaceutical (COLL) Share-based Compensation Growth (3y) (2017 - 2026)
Collegium Pharmaceutical (COLL) Share-based Compensation Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 10.06% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 9.14% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 0.43% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -8.13% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -1.73% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -8.04% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Collegium Pharmaceutical | 892.67 Mn | 743.35 Mn | 110.29 Mn | 11.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.98% |
| Mar 31, 2026 | 36.75% |
| Dec 31, 2025 | 62.28% |
| Sep 30, 2025 | 130.96% |
| Jun 30, 2025 | 137.98% |
| Mar 31, 2025 | 19.97% |
| Dec 31, 2024 | 40.11% |
| Sep 30, 2024 | 108.83% |
| Jun 30, 2024 | 100.20% |
| Mar 31, 2024 | 23.23% |
| Dec 31, 2023 | 175.81% |
| Sep 30, 2023 | 10.81% |
| Jun 30, 2023 | 8.19% |
| Mar 31, 2023 | 64.41% |
| Dec 31, 2022 | -3.88% |
| Sep 30, 2022 | 9.13% |
| Jun 30, 2022 | 11.00% |
| Mar 31, 2022 | 132.52% |
| Dec 31, 2021 | -28.27% |
| Sep 30, 2021 | 14.85% |